Complete versus incomplete revascularization in patients with multivessel disease undergoing percutaneous coronary intervention with drug-eluting stents

Catheterization and Cardiovascular Interventions

Volumn 72, Issue 4, 2008, Pages 448-456

  Tamburino, Corrado ^a   Angiolillo, Dominick J ^b   Capranzano, Piera ^a,b   Dimopoulos, Konstantinos ^c   La Manna, Alessio ^a   Barbagallo, Rossella ^a   Tagliareni, Francesco ^a   Mangiafico, Sarah ^a   Guzman, Luis A ^b   Galassi, Alfredo R ^a   Bass, Theodore A ^b  

^a UNIVERSITY OF CATANIA   (Italy)

^b UNIVERSITY OF FLORIDA COLLEGE OF MEDICINE   (United States)

^c ROYAL BROMPTON HOSPITAL   (United Kingdom)

Author keywords

Drug eluting stent; Multivessel disease; Revascularization strategy

Indexed keywords

BETA ADRENERGIC RECEPTOR BLOCKING AGENT; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; PACLITAXEL; RAPAMYCIN; CARDIOVASCULAR AGENT;

ADULT; ARTICLE; CIGARETTE SMOKING; CONTROLLED STUDY; CORONARY ARTERY BYPASS GRAFT; CORONARY ARTERY DISEASE; CORONARY ARTERY RECANALIZATION; DIABETES MELLITUS; DRUG ELUTING STENT; FAMILY HISTORY; FEMALE; FOLLOW UP; HEART DEATH; HEART INFARCTION; HUMAN; HYPERLIPIDEMIA; HYPERTENSION; INSULIN DEPENDENT DIABETES MELLITUS; MAJOR CLINICAL STUDY; MALE; PERCUTANEOUS CORONARY INTERVENTION; PROGNOSIS; REOPERATION; SURVIVAL RATE; TREATMENT OUTCOME; AGED; CARDIOVASCULAR DISEASE; COMPARATIVE STUDY; INSTRUMENTATION; KAPLAN MEIER METHOD; MIDDLE AGED; MORTALITY; PROPORTIONAL HAZARDS MODEL; REGISTER; RETROSPECTIVE STUDY; RISK ASSESSMENT; TIME; TRANSLUMINAL CORONARY ANGIOPLASTY;

AGED; ANGIOPLASTY, TRANSLUMINAL, PERCUTANEOUS CORONARY; CARDIOVASCULAR AGENTS; CARDIOVASCULAR DISEASES; CORONARY ARTERY DISEASE; DRUG-ELUTING STENTS; FEMALE; HUMANS; KAPLAN-MEIERS ESTIMATE; MALE; MIDDLE AGED; PACLITAXEL; PROPORTIONAL HAZARDS MODELS; REGISTRIES; RETROSPECTIVE STUDIES; RISK ASSESSMENT; SIROLIMUS; TIME FACTORS; TREATMENT OUTCOME;

EID: 58149232727     PISSN: 15221946     EISSN: 1522726X     Source Type: Journal    
DOI: 10.1002/ccd.21666     Document Type: Article

References (23)

1. Buda AJ, Macdonald IL, Anderson MJ, Strauss HD, David TE, Berman ND. Long-term results following coronary bypass operation: Importance of preoperative factors and complete revascularization. J Thorac Cardiovasc Surg 1981;82:383-390.
2. Jones EL, Craver JM, Guyton RA, Bone DK, Hatcher CR, Riechward N. Importance of complete revascularization in performance of the coronary bypass operation. Am J Cardiol 1983;51:7-12.
3. Bell MR, Gersh BJ, Schaff HV, Holmes DR, Fisher LD, Alderman EL, Myers WO, Parson LS, Reeder GS. Effect of completeness of revascularization on long-term outcome of patients with three-vessel disease undergoing coronary artery bypass surgery: A report from the Coronary Artery Surgery Study (CASS) Registry. Circulation 1992;86:446-457.
4. Kleisli T, Cheng W, Jacobs MJ, Mirocha J, Derobertis MA, Kass RM, Blanche C, Fontana GP, Raissi SS, Magliato KE, Trento A. In the current era, complete revascularization improves survival after coronary artery bypass surgery. J Thorac Cardiovasc Surg. 2005;129:1283-1291.
5. Vander Salm TJ, Kip KE, Jones RH, Schaff HV, Shemin RJ, Aldea GS, Detre KM. What constitutes optimal surgical revascularization? Answers from the bypass angioplasty revascularization investigation (BARI). J Am Coll Cardiol. 2002;39:565-572.
6. Van den Brand MJ, Rensing BJ, Morel MA, Foley DP, de Valk V, Breeman A, Suryapranata H, Haalebos MM, Wijns W, Wellens F, Balcon R, Magee P, Ribeiro E, Buffolo E. The effect of completeness of revascularization on event-free survival at one year in the ARTS trial. J Am Coll Cardiol 2002;19:559-564.
7. Kip KE, Bourassa MG, Jacobs AK, Schwartz L, Feit F, Alderman EL, Weiner BH, Weiss MB, Kellett MA Jr., Sharaf BL, Dimas AP, Jones RH, Sopko G, Detre KM. Influence of pre-PTCA strategy and initial PTCA result in patients with multivessel disease: The Bypass Angioplasty Revascularization Investigation (BARI). Circulation. 1999;100:910-917.
8. Bourassa MG, Yeh W, Holubkov R, Sopko G, Detre KM, for the Investigators of the NHLBI PTCA Registry. Long-term outcome of patients with incomplete vs. complete revascularization after multivessel PTCA: A report from the NHLBI Registry. Eur Heart J 1998;19:103-111.
9. McLellan CS, Ghali WA, Labinaz M, Davis RB, Galbraith PD, Southern DA, Shrive FM, Knudston ML. Association between completeness of percutaneous coronary revascularization and postprocedure outcomes. Am Heart J 2005;150:800-806.
10. Hannan EL, Racz M, Holmes DR, King SB, Walford G, Ambrose JA, Sharma S, Katz S, Clark LT, Jones RH. Impact of completeness of percutaneous coronary intervention revascularization on long-term outcomes in the stent era. Circulation. 2006;113:2406-2412.
11. Ijsselmuiden AJ, Ezechiels J, Westendorp IC, Tijssen JG, Kiemeneij F, Slagboom T, van der Wieken R, Tangelder G, Serruys PW, Laarman G. Complete versus culprit vessel percutaneous coronary intervention in multivessel disease: A randomized comparison. Am Heart J 2004;148:467-474.
12. Serruys PW, Ong ATL, van Herwerden LA, Sousa JE, Jatene AD, Bonnier JJ, Schonberger JP, Buller N, Bonser R, Disco C, Backx B, Firth B, Unger F. et al. Five-year outcomes after coronary stenting versus bypass surgery for the treatment of multivessel disease: The final analysis of the Arterial Revascularization Therapies Study (ARTS) Randomized Trial. J Am Coll Cardiol 2005;46:575-581.
13. Rodriguez AE, Baldi J, Fernandez Pereira C, Navia J, Rodriguez Alemparte M, Delacasa A, Vigo F, Vogel D, O'Neill W, Palacios IF, on behalf of the ERACI II Investigators. Five-year follow-up of the argentine randomized trial of coronary angioplasty with stenting versus coronary bypass surgery in patients with multiple vessel disease (ERACI II). J Am Coll Cardiol 2005;46: 582-588.
14. Serruys PW, Ong ATL, Morice MC, De Bruyne B, Colombo A, Macaya C, Richardt G, Fajadet J, Hamm C, Dawkins K, O'Malley J, Bressers M, Donohoe D, on behalf of the ARTS II Investigators. Arterial Revascularisation Therapies Study Part II., Sirolimus-eluting stents for the treatment of patients with multivessel de novo coronary artery lesions. Eur Intervention 2005;1:147-156.
15. Rodriguez AE, Maree AO, Grinfeld L, Fernandez Pereira C, Mieres J, Rodriguez Alemparte M, Berrocal D, Rodriguez-Granillo AM, Vigo CF, Russo Felsen M, O Neill W, Palacios I. Revascularization strategies of coronary multivessel disease in the drug-eluting stent era: One year follow-up results of the ERACI-III trial. Eur Intervention 2006;2:53-60.
16. Serruys PW, Unger F, Sousa JE, Jatene A, Bonnier HJ, Schonberger JP, Buller N, Bonser R, van den Brand MJ, van Herwerden LA, Morel MA, van Hout BA for the Arterial Revascularisation Therapies Study group. Comparison of coronary-artery bypass surgery and stenting for the treatment of multivessel disease. N Engl J Med 2001;344:1117-1124.
17. R Development Core Team. R: A language and environment for statistical computing. Vienna, Austria: R Foundation for Statistical Computing; 2006. ISBN 3-900051-07-0, Available at: http://www.R-project.org.
18. Ho D, Imai K, King G, Stuart E. Matching as nonparametric preprocessing for parametric causal inference. 2005. Available at: http://gking.harvard.edu/matchit/ (accessed February 14, 2007).
19. Suero JA, Marso SP, Jones PG, Laster SB, Huber KC, Giorgi LV, Johnson WL, Rutherford BD. Procedural outcomes and long-term survival among patients undergoing percutaneous coronary intervention of a chronic total occlusion in native coronary arteries: A 20-year experience. J Am Coll Cardiol 2001; 38:409-414.
20. Hoye A, van Domburg RT, Sonnenschein K, Serruys PW. Percutaneous coronary intervention for chronic total occlusions: The thoraxcenter experience 1992-2002. Eur Heart J 2005;26: 2630-2636.
21. Ong ATL, Serruys PW, Mohr FW, Morice MC, Kappetein AP, Holmes DR Jr, Mack MJ, van de Brand M, Morel MA, van Es GA, Kleijne J, Koglin J, Russell ME. The SYNergy between percutaneous coronary intervention with TAXus and cardiac surgery (SYNTAX) study: Design, rationale, and run-in phase. Am Heart J 2006;151:1194-1204.
22. Briguori C, Condorelli G, Airoldi F, Focaccio A, D'Andrea D, Cannavale M, Abarghouei AA, Giordano S, De Vivo F, Ricciardelli B, Colombo A. Comparison of coronary drug-eluting stent versus coronary artery bypass grafting in patients with diabetes mellitus. Am J Cardiol 2007;99:779-784.
23. Javaid A, Steinberg DH, Buch AN, Corso PJ, Boyce SW, Pinto Slottow TL, Roy PK, Hill P, Okabe T, Torguson R, Smith KA, Xue Z, Gevorkian N, Suddath WO, Kent KM, Satler LF, Pichard AD, Waksman R. Outcomes of coronary artery bypass grafting versus percutaneous coronary intervention with drug-eluting stents for patients with multivessel coronary artery disease. Circulation 2007;116:I-200-I-206.